These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 25386047

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Epigallocatechin gallate protects against homocysteine-induced vascular smooth muscle cell proliferation.
    Zhan XL, Yang XH, Gu YH, Guo LL, Jin HM.
    Mol Cell Biochem; 2018 Feb; 439(1-2):131-140. PubMed ID: 28871467
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Epigallocatechin-3-gallate inhibits interleukin-6- and angiotensin II-induced production of C-reactive protein in vascular smooth muscle cells.
    Peng N, Liu JT, Guo F, Li R.
    Life Sci; 2010 Mar 13; 86(11-12):410-5. PubMed ID: 20100497
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epigallocatechin-3-gallate protects HUVECs from PM2.5-induced oxidative stress injury by activating critical antioxidant pathways.
    Yang GZ, Wang ZJ, Bai F, Qin XJ, Cao J, Lv JY, Zhang MS.
    Molecules; 2015 Apr 14; 20(4):6626-39. PubMed ID: 25875041
    [Abstract] [Full Text] [Related]

  • 9. Docosahexaenoic acid (DHA)-induced heme oxygenase-1 attenuates cytotoxic effects of DHA in vascular smooth muscle cells.
    Stulnig G, Frisch MT, Crnkovic S, Stiegler P, Sereinigg M, Stacher E, Olschewski H, Olschewski A, Frank S.
    Atherosclerosis; 2013 Oct 14; 230(2):406-13. PubMed ID: 24075775
    [Abstract] [Full Text] [Related]

  • 10. Eupatolide inhibits PDGF-induced proliferation and migration of aortic smooth muscle cells through ROS-dependent heme oxygenase-1 induction.
    Kim N, Hwangbo C, Lee S, Lee JH.
    Phytother Res; 2013 Nov 14; 27(11):1700-7. PubMed ID: 23297002
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epigallocatechin-3-gallate attenuates microcystin-LR-induced apoptosis in human umbilical vein endothelial cells through activation of the NRF2/HO-1 pathway.
    Shi J, Zhang M, Zhang L, Deng H.
    Environ Pollut; 2018 Aug 14; 239():466-472. PubMed ID: 29679944
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Activation of M3AChR (Type 3 Muscarinic Acetylcholine Receptor) and Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) Signaling by Choline Alleviates Vascular Smooth Muscle Cell Phenotypic Switching and Vascular Remodeling.
    He X, Deng J, Yu XJ, Yang S, Yang Y, Zang WJ.
    Arterioscler Thromb Vasc Biol; 2020 Nov 14; 40(11):2649-2664. PubMed ID: 32938216
    [Abstract] [Full Text] [Related]

  • 20. Epigallocatechin-3-Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF-κB and Nrf2/HO-1 Signalling Pathway Regulation.
    Wang Y, Wang B, Du F, Su X, Sun G, Zhou G, Bian X, Liu N.
    Basic Clin Pharmacol Toxicol; 2015 Sep 14; 117(3):164-72. PubMed ID: 25625183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.